The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
ErbB-2 Amplification Inhibits Down-regulation and Induces Constitutive Activation of Both ErbB-2 and Epidermal Growth Factor Receptors
Open accessAbstract
ErbB-2/HER2 is an important signaling partner for the epidermal growth factor receptor (EGFR). Overexpression of erbB-2 is also associated with poor prognosis in breast cancer. To investigate how erbB-2 amplification affects its interactions with the EGFR, we used a human mammary epithelial cell system in which erbB-2 expression was increased 7-20-fold by gene transfection. We found that amplification of erbB-2 caused constitutive activation of erbB-2 as well as ligand-independent activation of the EGFR. Overexpression of erbB-2 strongly inhibited erbB-2 down-regulation following transactivation by EGFR. Significantly, down-regulation of activated EGFR was also inhibited by erbB-2 amplification, resulting in enhanced ligand-dependent activation of the EGFR. The rate of EGFR endocytosis was not affected by erbB-2 overexpression, but the rate of lysosomal targeting was significantly reduced. In addition, erbB-2 overexpression promoted rapid recycling of activated EGFR back to the cell surface and decreased ligand dissociation from the EGFR. Our data suggest that overexpression of erbB-2 inhibits both its down-regulation and that of the EGFR. The net effect is increased signaling through the EGFR system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435
Graus-Porta, D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1647 · Cited by 1,590
Guy, C. T., Webster, M. A., Schaller, M., Parsons, T. J., Cardiff, R. D., & Muller, W. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10578 · Cited by 1,193
Identification of Heregulin, a Specific Activator of p185 erbB2
Holmes, W. E., Sliwkowski, M. X., Akita, R. W., Henzel, W. J., Lee, J., Park, J. W., Yansura, D., Abadi, N., Raab, H., Lewis, G. D., et al. (1992) · Science · doi:10.1126/science.256.5060.1205 · Cited by 962
Pinkas-Kramarski, R., Soussan, L., Waterman, H., Levkowitz, G., Alroy, I., Klapper, L., Lavi, S., Seger, R., Ratzkin, B. J., Sela, M., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00603.x · Cited by 769
Alroy, I., & Yarden, Y. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00412-2 · Cited by 714
Plowman, G. D., Culouscou, J. M., Whitney, G. S., Green, J. M., Carlton, G. W., Foy, L., Neubauer, M. G., & Shoyab, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1746 · Cited by 713
ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
Karunagaran, D., Tzahar, E., Beerli, R. R., Chen, X., Graus-Porta, D., Ratzkin, B. J., Seger, R., Hynes, N. E., & Yarden, Y. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00356.x · Cited by 674
MEMBRANE-ANCHORED GROWTH FACTORS
Massagué, J., & Pandiella, A. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002503 · Cited by 660
A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling
Carraway, K. L., & Cantley, L. C. (1994) · Cell · doi:10.1016/0092-8674(94)90564-9 · Cited by 587
Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.
Alimandi, M., Romano, A., Curia, M. C., Muraro, R., Fedi, P., Aaronson, S. A., Fiore, P. P. D., & Kraus, M. H. (1995) · PubMed · Cited by 548
Gill, G. N., Kawamoto, T., Cochet, C., Le, A., Sato, J. D., Masui, H., McLeod, C., & Mendelsohn, J. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42857-2 · Cited by 455
All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired
Baulida, J., Kraus, M. H., Alimandi, M., Fiore, P. P. D., & Carpenter, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.5251 · Cited by 454
Lenferink, A. E. G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3385 · Cited by 413
Ligand-Induced Transformation by a Noninternalizing Epidermal Growth Factor Receptor
Wells, A., Welsh, J. B., Lazar, C. S., Wiley, H. S., Gill, G. N., & Rosenfeld, M. G. (1990) · Science · doi:10.1126/science.2305263 · Cited by 411
Self-citationStochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene
Bouchard, L., Lamarre, L., Tremblay, P. J., & Jolicoeur, P. (1989) · Cell · doi:10.1016/0092-8674(89)90331-0 · Cited by 393
Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4
Zhang, D., Sliwkowski, M. X., Mark, M., Frantz, G., Akita, R., Sun, Y., Hillan, K., Crowley, C., Brush, J., & Godowski, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9562 · Cited by 383
Earp, H. S., Dawson, T. L., Li, X., & Yu, H. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00694752 · Cited by 361
Enhanced Degradation of EGF Receptors by a Sorting Nexin, SNX1
Kurten, R. C., Cadena, D. L., & Gill, G. N. (1996) · Science · doi:10.1126/science.272.5264.1008 · Cited by 322
Wiley, H. S., Herbst, J. J., Walsh, B. J., Lauffenburger, D. A., Rosenfeld, M. G., & Gill, G. N. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99131-3 · Cited by 287
Self-citationLigands for ErbB-family receptors encoded by a neuregulin-like gene
Chang, H., Riese II, D. J., Gilbert, W., Stern, D. F., & McMahan, U. J. (1997) · Nature · doi:10.1038/387509a0 · Cited by 281
Neu and its ligands: From an oncogene to neural factors
Peles, E., & Yarden, Y. (1993) · BioEssays · doi:10.1002/bies.950151207 · Cited by 279
Endocytosis of growth factor receptors
Sorkin, A., & Waters, C. M. (1993) · BioEssays · doi:10.1002/bies.950150603 · Cited by 272
Tan, M., Yao, J., & Yu, D. (1997) · PubMed · Cited by 261
Wiley, H. S., & Cunningham, D. D. (1981) · Cell · doi:10.1016/0092-8674(81)90061-1 · Cited by 233
Self-citationWiley, H. S. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.2.801 · Cited by 230
Self-citationKing, C. R., Borrello, I., Bellot, F., Comoglio, P., & Schlessinger, J. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02991.x · Cited by 225
EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions.
Stern, D. F., & Kamps, M. P. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02906.x · Cited by 222
Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization.
Lund, K. A., Opresko, L. K., Starbuck, C., Walsh, B. J., & Wiley, H. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55456-9 · Cited by 210
Self-citationQian, X., LeVea, C., Freeman, J. K., Dougall, W. C., & Greene, M. I. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1500 · Cited by 173
Herbst, J. J., Opresko, L. K., Walsh, B. J., Lauffenburger, D. A., & Wiley, H. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99956-4 · Cited by 151
Self-citationBartek, J. J., Bártková, J., Kyprianou, N., Lalani, E., Stašková, Z., Shearer, M., Chang, S. E., & Taylor‐Papadimitriou, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3520 · Cited by 150
French, A. R., Sudlow, G., Wiley, H. S., & Lauffenburger, D. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40744-7 · Cited by 147
Self-citationOpresko, L. K., Chang, C.-P., Will, B. H., Burke, P. M., Gill, G. N., & Wiley, H. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.9.4325 · Cited by 147
Self-citationSorkin, A. D., Fiore, P. P. D., & Carpenter, G. (1993) · PubMed · Cited by 139
Secondary Dimerization between Members of the Epidermal Growth Factor Receptor Family
Gamett, D. C., Pearson, G. W., Cerione, R. A., & Friedberg, I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12052 · Cited by 98
Ligand and p185c-neu density govern receptorinteractions and tyrosine kinase activation.
Samanta, A., LeVea, C., Dougall, W. C., Qian, X., & GREENE, M. I. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1711 · Cited by 94
Gilboa, L., Ben-Levy, R., Yarden, Y., & Henis, Y. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7061 · Cited by 76
Ram, T. G., & Ethier, S. P. (1996) · PubMed · Cited by 73
Wright, J. D., Reuter, C. W., & Weber, M. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.12085 · Cited by 71
Worthylake, R. A., & Wiley, H. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8594 · Cited by 41
Self-citationInvolvement of the neuregulins and their receptors in cardiac and neural development
Carraway, K. L. (1996) · BioEssays · doi:10.1002/bies.950180403 · Cited by 38
Carraway, K. L., III, & Cerione, R. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80465-7 · Cited by 28
Cited by
Epidermal growth factor receptor (EGFR) signaling in cancer
Normanno, N., De Luca, A., Bianco, C., Strizzi, L., Mancino, M., Maiello, M. R., Carotenuto, A., De Feo, G., Caponigro, F., & Salomon, D. S. (2006) · Gene · doi:10.1016/j.gene.2005.10.018 · Cited by 2,038
EGF–ERBB signalling: towards the systems level
Citri, A., & Yarden, Y. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1962 · Cited by 2,004
Konecny, G. E., Pegram, M. D., Venkatesan, N., Finn, R., Yang, G., Rahmeh, M., Untch, M., Rusnak, D. W., Spehar, G., Mullin, R. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1182 · Cited by 914
Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth
Agus, D. B., Akita, R. W., Fox, W. D., Lewis, G. D., Higgins, B., Pisacane, P. I., Lofgren, J. A., Tindell, C., Evans, D. P., Maiese, K., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00097-1 · Cited by 873
Endocytosis and intracellular trafficking of ErbBs
Sorkin, A., & Goh, L. K. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.07.029 · Cited by 756
Metadata
- Authors
- Worthylake, R., Opresko, L. K., & Wiley, H. S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-03
- Volume
- 274
- Issue
- 13
- Pages
- 8865-8874
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2129936304
- Cited by
- 325
- References
- 45
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.